Azoospermia in a patient receiving interferon alpha for a stage III melanoma.
Longo
Isabel
I
Sánchez-Mateos
Paloma
P
Lázaro
Pablo
P
Longo
Natividad
N
D000328:Adult; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging; D009845:Oligospermia / Q000139:chemically induced* / Q000503:physiopathology; D011994:Recombinant Proteins; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013076:Sperm Count
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins